unknown by Barney S Graham
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessOral presentation
Clinical Trials of DNA and Recombinant Adenovector (rAd) 
Vaccines for HIV
Barney S Graham*‡
Address: Vaccine Research Center, NIAID, NIH, Bethesda, MD
Email: Barney S Graham* - bgraham@nih.gov
* Corresponding author    ‡Presenting author    
Background
Gene-based vaccine delivery is an important strategy for
induction of T cell responses that may be critical for a suc-
cessful AIDS vaccine. Despite promising results in animal
models, evidence of immune responses to DNA and rAd
vaccines in humans has been limited.
Materials and methods
Three Phase I studies have evaluated a series of DNA and
rAd vaccine candidates expressing constructs encoding
clades A, B, and C Envelope and clade B Gag and Pol with
or without Nef, as fusion proteins or individually.
Results
T cell and antibody responses are detected by IFN-α ELIS-
pot and FACS detection of intracellular IL-2 or IFN-α in
the large majority of vaccinees. Env peptide pools elicit
the strongest response, but the 6-plasmid and rAd product
also induced robust responses to Gag, Pol, and Nef. Both
T cell and humoral responses were dose dependent. The T
cell responses induced by DNA are detectable for at least
52 weeks, and the pattern of cytokine expression evolves
over time with fewer IFN-γ and more IL-2 producing T
cells at one year.
Conclusion
DNA and rAd5 vaccine candidates are well tolerated and
induce broad, durable immune responses. The combina-
tion will be tested in Phase II trials beginning 4Q2005.
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